Work

P3.12-06 SLFN11 Expression and Efficacy of PARP Inhibitor Therapy in Extensive Stage Small Cell Lung Cancer: ECOG-ACRIN 2511 Study

Year: 2018

Type: article

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2018.08.1829

Authors: T. Owonikoko, S. Dahlberg, G. Sica, J. Poirier, L. Byers, C. Rudin, I. Wistuba, S. Ramalingam

Institutions: Emory University, Dana-Farber Cancer Institute, Memorial Sloan Kettering Cancer Center, The University of Texas MD Anderson Cancer Center, Winship Cancer Institute

Language: English

Topic: Lung Cancer Research Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2896237464

FWCI:

Cites:

Cited by:

Related to: 10